القيمة السوقية تغيير تاريخ
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Arrowhead Research USD 11.5B 2.72B 2026-06
Astellas Pharma JPY 3.94T 622.52B 2026-06
BioCryst Pharmaceuticals USD 2.54B 880M 2026-06
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Cspc Pharmaceutical CNY 103.79B 16.5B 2026-03
Deva Holding AS TRY 17.54B 7.76B 2023-09
Divis Laboratories Ltd INR 1.75T 167.78B 2026-06
Exelixis USD 13.54B 2.65B 2026-06
Halozyme Therapeutics USD 9.28B 1.63B 2026-06
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Kangmei Pharma CNY 24.48B 3.45B 2026-03
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 133.52M 29.05M 2026-08
Medical Developments International AUD 62.53M 563.29K 2025-12
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novartis USD 240.59B 67.17B 2026-06
OPKO Health USD 2.73B 1.76B 2026-03
Organigram Holdings CAD 252.47M 59.69M 2026-03
Ovoca Bio EUR 1.17M 18.38K 2025-12
Pfizer USD 138.44B 15.37B 2026-06
Pharma Mar EUR 1.31B 263.2M 2026-06
Qiagen NV USD 8.07B 197.36M 2026-06
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sarepta Therapeutics USD 1.9B 388M 2026-06
Sartorius EUR 15.63B 1.38B 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06
Zealand Pharma A/S 20.84B 12.51B 2026-03
Zz Pientze Pharmaceu CNY 65.93B 25.23B 2026-06